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Tuberculosis and leprosy are chronic infectious diseases that presently affect 
more  than  65  million  people  (1,  2).  Apparently  the  majority  of individuals 
exposed to or infected with pathogenic mycobacteria develops effective immunity 
that is exclusively based on the cellular immune response, and recent evidence 
suggests that  T  helper/inducer  (T4)  lymphocytes are of particular  importance 
for protection (3-6). In previous studies whole bacteria or crude bacterial extracts 
have been used for stimulation of heterogeneous T  cell populations. Thus,  the 
bacterial proteins recognized by mycobacteria-reactive T  lymphocytes are com- 
pletely  unknown.  Recently,  a  64  kD  protein  antigen  of Mycobacterium  bovis 
bacillus Calmette-Guerin (BCG) has been cloned in Escherichia coli (7), and T  cell 
clones (TC) with reactivity to mycobacterial antigens have been established (8). 
It has therefore become possible to characterize defined mycobacterial antigens 
by  their  potential  to  stimulate  distinct  TC.  We  have  used  this  approach  to 
characterize the reactivity against a recombinant M.  bovis BCG antigen (antigen 
A) of human TC that were derived from a leprosy patient by in vitro stimulation 
with M.  leprae  and from three normal  PPD-reactive individuals by stimulation 
with  BCG.  This  is of particular  interest  for vaccine development,  and for the 
design of better-defined and more specific diagnostic skin test reagents. 
Materials and Methods 
Bacterial  and Antigen Preparations.  PPD was obtained from the Statens Serum Insti- 
tute, Copenhagen, Denmark. M.  leprae proteins (batch CD24) and irradiated M.  leprae 
organisms  (batch  CD20) were kindly supplied  by Dr.  R. J. W. Rees through the World 
Health Organization-Immunology of Leprosy (WHO-IMMLEP) program and had been 
prepared according to protocol 1/79, WHO document TDR, IMMLEP-SWG (S) 80.3. 
M. leprae cell wall preparation (batch IV) had been extracted from iyophilized M. leprae 
with chloroform/methanol, and was kindly provided by Dr.  P. Brennan, Colorado State 
Univ.,  Fort Collins, CO. M.  bovis BCG was originally  obtained from Dr.  R. J.  North, 
Trudeau Institute,  Saranac Lake, NY; M. intracullulare and M. avium were kindly provided 
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by Dr. W. Brehmer, Robert-Koch Institut, Berlin, Federal Republic of Germany; and M. 
tuberculosis was a kind gift of Dr. J. K. Seydel, Forschungsinstitut Borstel, Borstel, Federal 
Republic of Germany. Cultivable mycobacteria were grown in Bacto Dubos Broth (Difco 
Laboratories, Detroit, M I) supplemented with BSA and Tween 80 at 37 °C under shaking 
conditions.  Washed  mycobacteria were  heat-killed  and  ultrasonicated  at  60  W  (three 
times, 3 min each) using a Branson Sonifier B12 with microtip. For crude preparations of 
cell wall and cytoplasmic fractions, the sonicated material was centrifuged at 20,000 g for 
20 rain and separated pellets (cell wall-enriched) and supernatants (mainly cytoplasmic 
proteins) were used. 
Detection of M.  boris BCG Protein by SDS-PAGE.  20 t~g protein of E. coli iysates and 6 
~g protein of M.  bovis  BCG lysate were applied to SDS-polyacrylamide gels (0) of 7.5% 
acrylamide. After electrophoresis (3 h at 120 V, constant voltage) the separated proteins 
were silver stained (NEF-982; New England Nuclear, Boston, MA). 
Production  of Antigen A  by E.  coli KIZ  For the production of antigen A, we used E. 
coil K 12 host strain 1046 carrying the plasmids pCI857 plus pRIB 1000. Plasmid pRIB 1000 
is a recombinant DNA plasmid composed of the expression plasmid pPLc236 (10) and a 
4.9 kb M. bovis  BCG DNA fragment. The latter DNA fragment encodes for the antigen 
A  (7).  The expression of antigen  A  is low when  cells are  grown at  28°C  due  to the 
presence of the plasmid pCI857-encoded iambda repressor, which prevents transcription 
of the lambda promoter on plasmid pRIB1000. Overproduction occurs at 42°C due to 
inactivation of the thermolabile repressor. E. coli cells were grown to exponential phase 
in  NZYM medium (11) at 28°C and incubated overnight at 42°C.  After washing with 
saline, the cells were broken in a French press and centrifuged for 10 min at 10,000 g. 
The supernatant was used as a crude preparation of antigen A. As a control, similar cell 
extracts were made from E. coli KI2 1046, carrying only plasmid pCI857. 
Generation of Human T Cell Clones.  PBL of an Indian patient with tubercuioid leprosy 
classified on the basis of clinical and histopathoiogical criteria described by Ridley and 
Jopling  (12),  and  of three  healthy  PPD  ÷  donors  were  prepared  by  flotation  on  Fi- 
coll/metrizoate. Human T lymphocytes specific for mycobacterial proteins were stimulated 
in cultures of 1.5 ×  106 cells/ml in RPMI 1640 medium supplemented with 10% screened 
human A or AB serum, 2 mM L-glutamine, 25 mM Hepes buffer, 2 ×  10  -~ M 2-ME, 100 
U/ml penicillin, and 100 t~g/ml streptomycin in the presence of 10 ~g/ml of the respective 
soluble  antigen  or  107  cells/mi  heat-killed  and  sonicated  microorganisms.  PBL  bulk 
cultures from the leprosy patient were transferred from Bombay to Freiburg for further 
culturing and cloning. This patient was selected from others because of his covsiderable 
T cell reactivity in vitro and his HLA-DR phenotype (DR3), which also occurred frequently 
in a panel of pretested volunteers in F~eiburg who provided APC for maintaining antigen- 
specific T  cells.  After culture  for 7  d  in  24-well flat-bottomed microtiter trays (Nunc, 
Roskilde, Denmark), IL-2 was added (15  U/ml, Biotest, Frankfurt, Federal Republic of 
Germany) for 4  d.  Subsequently,  viable cells were separated on Ficoll/metriozate and 
plated at one cell per microculture well of 96-well round-bottom trays (Nunc) in medium 
containing 60 U/ml IL-2 together with 5 ×  104 autologous irradiated (4,000 rad) PBL, 
or plated at five cells]well with IL-2 (60 U]ml) and HLA-D-matched irradiated (4,000 
rad) PBL as APC. Both cultures also contained 10 #g/ml mycobacteriai protein in a total 
volume of 100 #1. T  cells from PPD-reactive donors were immediately cloned after the 
initial stimulation. After 10-14 d, growing clones could be transferred.  Subclones were 
obtained by recloning. Every 3-4 d, fresh IL-2 was added, and irradiated pooled feeders 
were added every 7 d. Before use in assay systems, TC were rested 6-7 d after the last 
addition of feeder cells.  Phenotype analysis was performed cytofluorometrically with the 
mAb OKT3, OKT4, OKT8, (Ortho Diagnostics, Westwood, MA), 
Proliferative Assay.  104 TC were incubated in 200-t~l triplicate cultures together with 
5  ×  104  irradiated (4,000  rad) HLA-D-matched PBL as APC, plus antigen,  in round- 
bottom microtiter wells  (Nunc).  Antigen concentrations are indicated in the  legend to 
Table I. After  72  h  of in vitro incubation at 37°C,  5%  CO~, humidified atmosphere, 
cultures were labeled for 16 h with  1 ~Ci of [SH]TdR per well, and harvested into glass 
fiber filters. [3H]TdR incorporation was measured in a liquid scintillation spectrometer. 1026  EMMRICH  ET  AL,  BRIEF  DEFINITIVE  REPORT 
Florae  1.  SDS-PAGE (7.5% polyacrylamide) of BCG lysate (A) compared to E.  coil lysates 
with (B) or without (C) the antigen A insert. Antigen A is marked by an arrow. 
Results and Discussion 
A  gene bank of M.  bovis  BCG has been constructed (7) in E.  coli by cloning 
mycobacterium DNA fragments into a  lambda cloning vehicle. Clones of this 
library have been screened for the production of mycobacterial antigens by using 
a polyclonal anti-M,  bovis BCG antiserum. ~50% of the antigen-positive clones 
produced one particular mycobacterial protein antigen, designated antigen A. 
This protein has an Mr of 64 kD on SDS-PAGE, and a variety of mycobacterial 
species as well as PPD preparations contain (7) proteins crossreacting with antigen 
A. In Fig.  1, at 64 kD, a prominent band can be seen in lysates of both BCG and 
E. coli expressing antigen A. Densitometric determinations showed that antigen 
A is ~2% of total protein in these crude extracts. 
We have tested the ability of antigen A  to stimulate human T4 clones using 
this crude lysate. 105 TC from a leprosy patient in the tuberculoid phase of the 
disease have been established initially by stimulation with a mixture ofM. leprae 
proteins and PPD (8).  11  T4 clones specific for either PPD (2 of 11), M.  leprae 
protein (5 of 11),  or crossreactive to both preparations (4 of 11) were selected 
because of their considerable growth after specific stimulation. All of them had 
the phenotype T3 +, T8-,  T4 +. The four crossreactive TC could also be stimu- 
lated by BCG. In Table I, proliferative responses of five representative TC are 
shown.  2G2  and  2D1,  which expressed selective reactivity towards  either M. 
leprae protein or PPD, could not be restimulated by antigen A. However, two of 
the three crossreactive TC (shown in Table I) that reacted with both PPD and 
34. leprae antigen were restimulated by antigen A. The response of clones 1H 11 
and 4F1  to 10 #g/ml PPD,  10 #g/ml M.  leprae protein, or 20/~g/ml of the E. 
coli  lysate  (containing  ~0.4  ~g/ml  protein  A),  respectively,  was  comparable, 
suggesting that the antigen recognized by these TC was identical in the different EMMRICH  ET  AL.  BRIEF  DEFINITIVE  REPORT  1027 
TABLE  I 
Stimulation  of Human  T4 Clones with Reactivity to Mycobacterial Proteins by Antigen A 
Antigen 
[SH]TdR uptake by T  cell clones [mean cpm (_+SD)] 
2C11  1  H11  4FI  2G2  2D1 
Control  254 (162)  60 (11)  48 (2)  129 (31)  64 (2) 
OVA  198 (36)  73 (19)  64 (16)  83 (26)  77 (5) 
PPD  35,272 (188)  7,959 (18)  1,360 (13)  85 (13)  11,086 (195) 
M. leprae protein  84,500 (9,625)  5,949 (443)  1,024 (43)  13,760 (93)  91 (10) 
K12  141 (57)  74 (12)  70 (22)  42 (13)  65 (30) 
KI 2 + antigen A  146 (70)  4,489 (642)  1,496 (27)  58 (26)  104 (31) 
10 * T  cells from TC were stimulated with 10 t~g/ml PPD,  10 ug/ml of a protein preparation from M. leprae, 20 
#g/ml of E, coil protein (E. coli K12 lysate),  and antigen A produced by E. coli K12 (KI2 +  antigen A) together 
with 5 X 10  * irradiated (4,000 tad) HLA-D-matched PBL. No stimulation was observed by the APC alone, as can 
be seen from the comparison of TC alone (control) and TC cultured with PBL together with an irrelevant protein 
(OVA). Stimulation was assessed in triplicates by the incorporation of [SH]TdR in a 72-h assay; SD in parentheses. 
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FIGURE  2.  Stimulation pattern of four TC from a leprosy patient using a panel of mycobac- 
terial antigen preparations.  Four independent clones with reactivity to mycobacterial antigens 
were cultured with APC and different antigen preparations. Protein concentrations or numbers 
of mycobacterial  organisms per culture are:  (1) M. leprae,  10n; (2) sonicated M.  leprae,  10s; 
(3) M. leprae protein,  10 ~,g/ml; (4) M. leprae cell wall fraction,  10 #g/ml; (5) sonicated BCG, 
106; (6) BCG cell wall fraction,  10 ~g/ml; (7) BCG cytoplasm fraction,  10 t~g/ml; (8) sonicated 
M. tuberculosis,  106; (9) M. tuberculosis cell wall fraction, 10 ~g/ml; (I0) M. tuberculosis cytoplasm 
fraction,  10 #g/ml; (11) PPD,  10 ~g/ml; (12) sonicated M. intracellulare,  106; (13) sonicated 
M. avium,  106; (14) E. coli K12,  20 ~g/ml; (15) E. coli K12 expressing antigen A, 20/~g/ml; 
(16) IL-2, 8 U/ml. Stimulation was assessed by [SH]TdR incorporation, and stimulation indices 
were calculated as test cpm divided by control cpm (see Table I; cpm values with OVA). Note 
that stimulation indices are shown in logarithmic scale. 
antigen preparations.  The control E.  coli extract had no mitogenic effect for 
these TC (Table I). TC were not stimulated by antigen alone, indicating depend- 
ence on presentation by APC (data not shown). In Fig. 2, proliferation profiles 1028  EMMRICH  ET  AL.  BRIEF  DEFINITIVE  REPORT 
of TC  1H11,  4F1,  2C11,  and  2D1  in  response  to a  variety of mycobacterial 
antigens  are  shown  in  a  logarithmic  scale.  Clone  2C11  expressed  a  broad 
reactivity pattern to several mycobacterial antigens including M.  avium and M. 
intracellulare, whereas clone 2D1 showed a distinct and more restricted pattern. 
A  third  type of stimulation  profile  was  shared  by  TC  1Hll  and  4F1,  both 
reactive to antigen A.  These similarities in their proliferation profiles indicate 
that the same antigen was recognized by TC 1H 11 and 4F 1. 
Panels of BCG-reactive TC were established from three healthy PPD  + donors 
to estimate the proportion of antigen A-reactive T  cells among them. The initial 
stimulation  with  BCG  was  followed  immediately by  cloning  under  limiting- 
dilution conditions to minimize in vitro selection. The frequency of antigen A- 
reactive TC varied. Out of those TC that could be restimulated significantly by 
BCG,  in three distinct donors, 45  of 66,  3 of 12, and none of 8,  respectively, 
were reactive with antigen A, suggesting that this antigen for some individuals 
may be an important T  cell antigen. 
Recently, a recombinant protein of M. bovis BCG has been produced (7), and 
this offered the possibility of defining T  cell antigens by means of mycobacteria- 
reactive TC (8).  It was encouraging to find that whole E.  coli lysates containing 
the relevant antigen did not exert suppressive effects for specific stimulation of 
TC  (see Table  I),  thus  facilitating screening assays  with  transfected proteins 
without need for prior purification. 
The individual stimulation patterns of TC 2H 11 and 4F1 in the presence of a 
variety of crude mycobacterial extracts were similar, indicating that these TC 
recognized the same antigen. This approach may be useful for defining major T 
cell antigens by comparing stimulation profiles of a  large number of TC estab- 
lished under minimal in vitro selection pressure, with undefined antigen extracts. 
TC with the most frequent stimulation pattern should recognize a major T  cell 
antigen, and representative TC could be used for identification of the homolo- 
gous antigen in different preparations during the course of purification. 
Although it seems suggestive, the observation that many T  cells recognize the 
same  antigen  does  not  necessarily  imply  a  protective  role  for  this  antigen. 
Therefore, additional criteria are needed. Acquired resistance against mycobac- 
teria depends on specific T  lymphocytes (1,  2),  and present evidence suggests 
that these are T4 ÷, T8- cells that produce IFN-3, and/or macrophage activating 
factor (3-6).  Therefore, identification of protective antigens might be possible 
with TC that meet these requirements. Our antigen A-reactive TC, 2H11  and 
4F1, express the T4 ÷, T8-phenotype, and after stimulation with antigen secrete 
IFN-3,  (8),  and  hence may exert antibacterial  activity.  Besides  this  deductive 
characterization, at present there is no other way for defining T  cell antigens as 
protective at the preclinical level. Fortunately, a considerable number of BCG- 
reactive  TC  from  healthy  individuals  and  from  a  leprosy  patient  could  be 
stimulated. However, further investigations on frequencies of antigen A-reactive 
TC in patients with different mycobacterial diseases are needed to estimate the 
role and the potential use of antigen A as T  cell antigen in these diseases. 
Summary 
A recombinant 64 kD protein ofMycobacterium bovis bacillus Calmette-Guerin 
(BCG) (antigen A), which amounted to ~2% of an E.  coli lysate, was tested for EMMRICH  ET  AL.  BRIEF  DEFINITIVE  REPORT  1029 
its  capacity to stimulate  human  T4  clones reactive to  mycobacterial proteins. 
Two out of four crossreactive clones, established from a patient with tuberculoid 
leprosy, which could be stimulated by protein preparations of M.  leprae and M. 
tuberculosis,  and  by particulate M.  bovis  BCG  were also  reactive to antigen  A 
without further enrichment from E.  coli lysate. In addition, BCG-reactive T  cell 
clones from  two  of three healthy  PPD  ÷ donors  reacted  with  antigen A.  This 
finding shows that human T  cell clones may be useful for probing gene-cloned 
proteins of potential value for vaccination against  diseases where protection is 
mediated exclusively by T  cells. 
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